Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-24-000015

Chief Business Officer gave up 1,735 shares (to pay taxes)

  • Chief Business Officer acquired 27,300 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Boyle Scott N · Chief Business Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-13 Shares withheld for taxes : show line 1 in the form −1,735 $6.53 $11,330 25,030 D
2024-02-14 Grant or award : show line 2 in the form +27,300 52,330 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-14 Grant or award : show line 3 in the form Stock Option (Right to Buy) +122,800 122,800 D
Loading xslF345X05/wk-form4_1708034573.xml…